Myriad Genetics (MYGN) –
-
Form 4 MYRIAD GENETICS INC For: Dec 01 Filed by: Riggsbee Richard Bryan
-
Myriad Genetics Celebrates One Million SneakPeekĀ® Results Shared with Expectant Parents
-
Myriad Genetics (MYGN) and Personalis Partner to Market Solutions to Pharma Customers
-
Myriad Genetics and Personalis Partner to Market SolutionsĀ to Pharma Customers
-
Form 8-K MYRIAD GENETICS INC For: Nov 08
-
Form 424B5 MYRIAD GENETICS INC
-
Myriad Genetics to Participate in Stephens Annual Investment Conference
-
Form 8-K MYRIAD GENETICS INC For: Nov 08
-
Myriad Genetics (MYGN) Prices Upsized 6.47M Share Offering at $17/sh
-
Myriad Genetics Announces Pricing of Upsized Offering of Common Stock
-
Myriad Genetics (MYGN) Announces Proposed $100M Share Offering
-
Myriad Genetics Announces Proposed Offering of $100 Million of Shares of Common Stock
-
Form 424B5 MYRIAD GENETICS INC
-
Form S-3ASR MYRIAD GENETICS INC
-
Form 10-Q MYRIAD GENETICS INC For: Sep 30
-
Myriad Genetics (MYGN) Tops Q3 EPS by 5c
-
Form 8-K MYRIAD GENETICS INC For: Nov 06
-
Myriad Genetics Reports Third Quarter 2023 Financial Results; Generates Double-Digit Revenue Growth; Raises 2023 Revenue Guidance and Introduces 2024 Revenue Guidance
-
Form 4 MYRIAD GENETICS INC For: Nov 01 Filed by: Riggsbee Richard Bryan
-
Form 144 MYRIAD GENETICS INC Filed by: Riggsbee Richard Bryan
-
Form 4 MYRIAD GENETICS INC For: Oct 31 Filed by: Lambert Nicole
-
Form 8-K MYRIAD GENETICS INC For: Nov 01
-
Myriad Genetics (MYGN) Appoints Sam Raha as Chief Operating Officer
-
Myriad Genetics Appoints Sam Raha as Chief Operating Officer
-
Form 8-K MYRIAD GENETICS INC For: Oct 31
-
Myriad Genetics to Release Third Quarter Financial Results on November 6, 2023
-
Myriad Genetics (MYGN) and QIAGEN (QGEN) partner over diagnostics development for cancer
-
QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer
-
Myriad Genetics (MYGN) PT Lowered to $18 at BofA Securities
-
Form 4 MYRIAD GENETICS INC For: Oct 18 Filed by: Wong Pamela
-
Form SC 13G MYRIAD GENETICS INC Filed by: INTEGRATED CORE STRATEGIES (US) LLC
-
Form 8-K MYRIAD GENETICS INC For: Oct 10
-
Form 4 MYRIAD GENETICS INC For: Oct 09 Filed by: Riggsbee Richard Bryan
-
Form 4 MYRIAD GENETICS INC For: Oct 09 Filed by: Verratti Mark
-
Form 4 MYRIAD GENETICS INC For: Oct 09 Filed by: Lambert Nicole
-
Form 4 MYRIAD GENETICS INC For: Oct 09 Filed by: Haas Kevin Richard
-
Form 4 MYRIAD GENETICS INC For: Oct 09 Filed by: Muzzey Dale
-
Form 8-K MYRIAD GENETICS INC For: Oct 04
-
BREAST CANCER AWARENESS MONTH: NEW CANCER RISK SURVEY REVEALS RISK FACTORS ARE WIDELY MISUNDERSTOOD
-
New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood
-
Form 4 MYRIAD GENETICS INC For: Sep 26 Filed by: Riggsbee Richard Bryan
-
Form 4 MYRIAD GENETICS INC For: Sep 26 Filed by: Verratti Mark
-
Form 4 MYRIAD GENETICS INC For: Sep 26 Filed by: Lambert Nicole
-
Form 4 MYRIAD GENETICS INC For: Sep 26 Filed by: Haas Kevin Richard
-
Form 4 MYRIAD GENETICS INC For: Sep 26 Filed by: Muzzey Dale
-
Form 4 MYRIAD GENETICS INC For: Sep 21 Filed by: Munk Natalie
-
Form 4 MYRIAD GENETICS INC For: Sep 21 Filed by: Ancona Margaret
-
Form 4 MYRIAD GENETICS INC For: Sep 21 Filed by: Verratti Mark
-
Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials
-
Myriad Genetics Issues 2022 Environmental, Social and Governance Report
Back to MYGN Stock Lookup